Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ocular health.
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.
Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.
More than five years since COVID was declared a pandemic, we're still facing the regular emergence of new variants of the ...
The latest variant on the rise is LP.8.1. It’s increasing in Australia, making up close to one in five COVID cases in New ...
COVID-19 as a whole is still a major national and international health concern. So far this year, there have been close to 45 ...
More than five years since COVID was declared a pandemic , we're still facing the regular emergence of new variants of the virus, SARS-CoV-2.Author ...
Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback